Dr. Oscar Reig Torras
Claim this profileHospital Clínic de Barcelona
More about Oscar Reig Torras
Clinical Trial Related
6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Oscar Reig Torras has experience with
- Cabozantinib
- Avelumab
- M6223
- NKTR-255
- Sacituzumab Govitecan
Breakdown of trials Oscar Reig Torras has run
Renal Cell Carcinoma
Kidney Cancer
Transitional Cell Carcinoma
Bladder Cancer
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Oscar Reig Torras specialize in?
Oscar Reig Torras focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved treating patients, or patients who are undergoing treatment.
Is Oscar Reig Torras currently recruiting for clinical trials?
No, Oscar Reig Torras is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Oscar Reig Torras has studied deeply?
Yes, Oscar Reig Torras has studied treatments such as Cabozantinib, Avelumab, M6223.
What is the best way to schedule an appointment with Oscar Reig Torras?
Apply for one of the trials that Oscar Reig Torras is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.